Integrated Mathematical Oncology Faculty

Integrated Mathematical Oncology faculty consists of seven internationally renowned cancer researchers and mathematical modelers. The focus of all IMO research groups is to apply physical, mathematical and mechanical principles to cancer biology to decipher first order principles of tumor growth that can be exploited for novel cancer treatments.  

Anderson

Alexander Anderson, PhD – Chair

Mathematical models, in general, have suffered greatly due to a lack of true experimental parameterization and derivation with Integrated Mathematical Oncology, we hope to address this issue and develop truly integrated models of specific cancers that can have both predictive and therapeutic application.

Moffitt Profile | Lab website  


Philipp AltrockPhilipp Altrock, PhD – Assistant Member

We apply theoretical evolutionary biology models, together with computational, bioinformatics and statistical approaches to cancer cell biology. Of particular interest to us is how the tumor microenvironment shapes selective pressures that play a fundamental role in the evolution of tumor progression and resistance to therapy.

Moffitt Profile | Lab website 


Noemi AndorNoemi Andor, PhD – Assistant Member

Moffitt Profile


David BasantaDavid Basanta, PhD – Associate Member

If we are going to understand and learn how to exert some control in cancer progression we need methods and approaches that can handle this evolutionary and ecological perspective of cancer. Given the complexity of this disease, mathematical and computational methods are not only useful but also necessary. For this reason, my work focuses on mathematical and computational models of cancer evolution. 

Moffitt Profile 


Joel BrownJoel Brown, PhD – Senior Member

As member of the Cancer Biology and Evolution Group and the Department of Integrated Mathematical Oncology, my research and collaborations are multi-disciplinary. I have ongoing collaborations with Drs. Robert Gatenby and Sandy Alexander on applying ecological principles to understanding cancer. In terms of experimental work, I enjoy collaborative work on skin cancer cell culturing with Ken Tsai, competition experiments to explore the cost of resistance with Dr. Robert Gillies and his group, mouse model work on prostate cancer and the evolution of cancer resistance with Drs. Gatenby and Arig Ibrahim.

Moffitt Profile 


Heiko EnderlingHeiko Enderling, PhD – Associate Member

Dr. Enderling's research interests are focused on developing clinically and experimentally motivated and quantitative models of cell-cell interactions within a tumor as well as at the tumor-host interface. In particular, the work in his laboratory focuses on the role of cancer stem cells in tumor progression and treatment response, with the ultimate goal to improve patient-specific treatment design.

Moffitt Profile | Lab website 


Robert GatenbyRobert Gatenby, MD – Senior Member

Dr. Gatenby spearheaded the formation of a new program at Moffitt titled Integrative Mathematical Oncology (IMO). The IMO brings to the Cancer Center a cadre of applied mathematicians to collaborate with tumor biologists and clinical oncologists. The goal is to use the mathematics developed for other nonlinear dynamical systems to examine the physiology of a tumor incorporating factors such as phenotypic evolution, intracellular communication pathways and interactions with microenvironmental factors including therapies.

Moffitt Profile


Katarzyna RejniakKatarzyna Rejniak, PhD – Associate Member

My ultimate research goal is to integrate the IBCell model with the experimental and clinical data to provide a tool for simulating the growth of tumor cells in different tissues and under various external conditions. The model can be adjusted to represent distinct biomechanical properties of the tissue under consideration and can be extended to include distinct biochemical properties of the host cells, therefore it shows a promise in providing a supporting evaluation of the tumorigenic potential of the collected cell samples and in testing in silico various protocols for patient-specific treatment.

Moffitt ProfileLab website